A clinical trial found that NOD1 and NOD2 mRNA expression in peripheral blood mononuclear cells from people with type 2 diabetes was positively correlated with insulin resistance and glycemic abnormalities (112). Here, NOD1 is linked to type 2 diabetes mellitus.